- Report
- January 2024
- 114 Pages
United States
€3217EUR$3,500USD£2,685GBP
- Report
- January 2024
- 35 Pages
United States
- Report
- January 2024
- 95 Pages
United States
€3217EUR$3,500USD£2,685GBP
- Report
- January 2024
- 39 Pages
United States
- Report
- January 2024
- 156 Pages
United States
€3492EUR$3,800USD£2,916GBP
- Report
- January 2024
- 113 Pages
United States
€3217EUR$3,500USD£2,685GBP
- Report
- January 2024
- 109 Pages
United States
€3217EUR$3,500USD£2,685GBP
- Report
- January 2024
- 120 Pages
United States
€3217EUR$3,500USD£2,685GBP
- Report
- January 2024
- 26 Pages
Global
€15762EUR$17,150USD£13,158GBP
- Report
- January 2024
- 120 Pages
Global
From €7307EUR$7,950USD£6,100GBP
- Report
- December 2023
- 102 Pages
Global
From €4549EUR$4,950USD£3,798GBP
- Report
- December 2023
- 22 Pages
Global
From €2298EUR$2,500USD£1,918GBP
- Report
- December 2023
- 61 Pages
Global
From €13781EUR$14,995USD£11,505GBP
- Report
- December 2023
- 109 Pages
Global
From €2298EUR$2,500USD£1,918GBP
- Report
- December 2023
- 230 Pages
Global
From €2252EUR$2,450USD£1,880GBP
- Report
- November 2023
- 67 Pages
Global
From €2711EUR$2,950USD£2,263GBP
- Report
- November 2023
- 162 Pages
Global
From €2298EUR$2,500USD£1,918GBP
- Report
- November 2023
- 120 Pages
Global
From €4274EUR$4,650USD£3,568GBP
- Report
- November 2023
- 66 Pages
Global
From €2252EUR$2,450USD£1,880GBP
- Report
- November 2023
- 171 Pages
Global
From €4274EUR$4,650USD£3,568GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more